. Insee, Pyramide des âges par état matrimonial 2018 -France métropolitaine Séries de, 1901.

D. Sur,

. Insee, Pyramide des âges : projections de population 2050 -Régions et départements Séries de, 2013.

R. J. Havighurst, Successful Aging. Gerontologist. 1 mars, vol.1, issue.1, pp.8-13, 1961.

J. W. Rowe and R. L. Kahn, Successful aging, Gerontologist. août, vol.37, issue.4, pp.433-473, 1997.

S. Kusumastuti, M. Derks, S. Tellier, D. Nucci, E. Lund et al., Successful ageing: A study of the literature using citation network analysis, Maturitas. nov, vol.93, pp.4-12, 2016.

J. W. Rowe and R. L. Kahn, Successful Aging 2.0: Conceptual Expansions for the 21st Century, J Gerontol B Psychol Sci Soc Sci. 1 juill, vol.70, issue.4, pp.593-599, 2015.

R. Tkatch, S. Musich, S. Macleod, K. Alsgaard, K. Hawkins et al., Population Health Management for Older Adults: Review of Interventions for Promoting Successful Aging Across the Health Continuum, Gerontol Geriatr Med. déc, vol.2, p.2333721416667877, 2016.

C. Daskalopoulou, B. Stubbs, C. Kralj, A. Koukounari, M. Prince et al., Physical activity and healthy ageing: A systematic review and meta-analysis of longitudinal cohort studies, Ageing Res Rev. sept, vol.38, pp.6-17, 2017.

L. F. Carver and D. Buchanan, Successful aging: considering non-biomedical constructs, Clin Interv Aging, vol.11, pp.1623-1653, 2016.

I. Bosnes, H. M. Nordahl, E. Stordal, O. Bosnes, T. Å. Myklebust et al., Lifestyle predictors of successful aging: A 20-year prospective HUNT study, PLoS ONE, vol.14, issue.7, p.219200, 2019.

, Comment améliorer la qualité et la sécurité des prescriptions de médicaments chez la personne âgée ?, HAS

H. Autorité-de-santé, , 2014.

D. Sur,

A. H. Lavan, P. F. Gallagher, O. 'mahony, and D. , Methods to reduce prescribing errors in elderly patients with multimorbidity, Clin Interv Aging, vol.11, pp.857-66, 2016.

T. M. Liew, C. S. Lee, K. L. Goh-shawn, and Z. Y. Chang, Potentially Inappropriate Prescribing Among Older Persons: A Meta-Analysis of Observational Studies, Ann Fam Med, vol.17, issue.3, pp.257-66, 2019.

H. Park, H. Satoh, A. Miki, H. Urushihara, and Y. Sawada, Medications associated with falls in older people: systematic review of publications from a recent 5-year period, Eur J Clin Pharmacol. déc, vol.71, issue.12, pp.1429-1469, 2015.

L. J. Seppala, A. Wermelink, M. De-vries, K. J. Ploegmakers, E. Van-de-glind et al., Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics, J Am Med Dir Assoc, vol.19, issue.4, pp.371-382, 2018.

P. O. Lang, M. Dramé, B. Guignard, R. Mahmoudi, I. Payot et al., Les critères STOPP/START.v2 : adaptation en langue française, NPG Neurologie -Psychiatrie -Gériatrie. 1 déc, vol.15, issue.90, pp.323-359, 2015.

R. E. Thomas and B. C. Thomas, A Systematic Review of Studies of the STOPP/START 2015 and American Geriatric Society Beers 2015 Criteria in Patients ? 65 Years, Curr Aging Sci, vol.12, issue.2, pp.121-54, 2019.

S. Thevelin, L. E. Mounaouar, S. Marien, B. Boland, S. Henrard et al., Potentially Inappropriate Prescribing and Related Hospital Admissions in Geriatric Patients: A Comparative Analysis between the STOPP and START Criteria Versions 1 and 2, Drugs Aging, vol.36, issue.5, pp.453-462, 2019.

D. Counter, J. Millar, and J. S. Mclay, Hospital readmissions, mortality and potentially inappropriate prescribing: a retrospective study of older adults discharged from hospital, Br J Clin Pharmacol. août, vol.84, issue.8, pp.1757-63, 2018.

M. Wauters, M. Elseviers, B. Vaes, J. Degryse, O. Dalleur et al., Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old, Br J Clin Pharmacol, vol.82, issue.5, pp.1382-92, 2016.

E. Blanco-reina, M. R. García-merino, R. Ocaña-riola, L. Aguilar-cano, J. Valdellós et al., Assessing Potentially Inappropriate Prescribing in Community-Dwelling Older Patients Using the Updated Version of STOPP-START Criteria: A Comparison of Profiles and Prevalences with Respect to the Original Version, PLoS ONE, vol.11, issue.12, p.167586, 2016.

O. Semoun and C. Sevilla-dedieu, Psychotropic Drug Consumption Among Older People Enrolled in a French Private Health Insurance Plan, Drugs Real World Outcomes. 17 juill, vol.2, issue.3, pp.217-242, 2015.

A. Hiance-delahaye, F. M. De-schongor, L. Lechowski, L. Teillet, J. Arvieu et al., Potentially inappropriate prescription of antidepressants in old people: characteristics, associated factors, and impact on mortality, Int Psychogeriatr, vol.30, issue.5, pp.715-741, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01764264

H. Van-spall, A. Toren, A. Kiss, and R. A. Fowler, Eligibility criteria of randomized controlled trials published in highimpact general medical journals: a systematic sampling review, JAMA. 21 mars, vol.297, issue.11, pp.1233-1273, 2007.

A. Clegg, J. Young, S. Iliffe, M. O. Rikkert, and K. Rockwood, Frailty in elderly people, Lancet. 2 mars, vol.381, issue.9868, pp.752-62, 2013.

G. Gavazzi, Fragilité et vieillissement, concept et définitions. revinf, vol.66, pp.18-20, 2017.

U. Junius-walker, G. Onder, D. Soleymani, B. Wiese, O. Albaina et al., The essence of frailty: A systematic review and qualitative synthesis on frailty concepts and definitions, Eur J Intern Med, vol.56, pp.3-10, 2018.

H. X. Liu, G. Ding, W. J. Yu, T. F. Liu, A. Y. Yan et al., Association between frailty and incident risk of disability in community-dwelling elder people: evidence from a meta-analysis. Public Health, vol.175, pp.90-100, 2019.

R. Ofori-asenso, L. Chin, K. Mazidi, M. Zomer, E. Ilomaki et al., Natural Regression of Frailty Among Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis, Gerontologist, vol.15, issue.2020, pp.286-98

S. Chang, H. Lin, and C. Cheng, The Relationship of Frailty and Hospitalization Among Older People: Evidence From a Meta-Analysis, J Nurs Scholarsh, vol.50, issue.4, pp.383-91, 2018.

T. F. Crocker, L. Brown, A. Clegg, K. Farley, M. Franklin et al., Quality of life is substantially worse for community-dwelling older people living with frailty: systematic review and meta-analysis, Qual Life Res. août, vol.28, issue.8, pp.2041-56, 2019.

M. Cheng and C. , Frailty as a Risk Factor for Falls Among Community Dwelling People: Evidence From a Meta-Analysis, J Nurs Scholarsh, vol.49, issue.5, pp.529-565, 2017.

L. Zheng, G. Li, D. Gao, S. Wang, X. Meng et al., Cognitive frailty as a predictor of dementia among older adults: A systematic review and meta-analysis, Arch Gerontol Geriatr. avr, vol.87, p.103997, 2020.

E. Reallon, B. Chavent, F. Gervais, V. Dauphinot, J. Vernaudon et al., Medication exposure and frailty in older community-dwelling patients: a cross-sectional study, Int J Clin Pharm. avr, vol.42, issue.2, pp.508-522, 2020.

K. Palmer, E. R. Villani, D. L. Vetrano, A. Cherubini, A. J. Cruz-jentoft et al., Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis, Eur Geriatr Med. févr, vol.10, issue.1, pp.9-36, 2019.

N. Masnoon, S. Shakib, L. Kalisch-ellett, and G. E. Caughey, What is polypharmacy? A systematic review of definitions, BMC Geriatr, vol.10, issue.1, p.230, 2017.

M. Monégat and C. Sermet, La polymédication : définitions, mesures et enjeux. Revue de la littérature et tests de mesure -IRDES. Questions d'économie de la santé, déc, issue.204, p.8, 2014.

A. Cherubini, A. Corsonello, and F. Lattanzio, Underprescription of beneficial medicines in older people: causes, consequences and prevention, Drugs Aging. 1 juin, vol.29, issue.6, pp.463-75, 2012.

F. R. Motter, J. S. Fritzen, S. N. Hilmer, É. V. Paniz, and V. Paniz, Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria, Eur J Clin Pharmacol. juin, vol.74, issue.6, pp.679-700, 2018.

F. Montastruc, C. Duguet, V. Rousseau, H. Bagheri, and J. Montastruc, Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database, Eur J Clin Pharmacol. sept, vol.70, issue.9, pp.1123-1130, 2014.

P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, D. O'mahony et al., Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation, Int J Clin Pharmacol Ther. févr, vol.46, issue.2, pp.72-83, 2008.

A. Desnoyer, B. Guignard, P. Lang, J. Desmeules, N. Vogt-ferrier et al.,

, Presse Med. nov, vol.45, issue.11, pp.957-70, 2016.

B. Hill-taylor, I. Sketris, J. Hayden, S. Byrne, D. O'sullivan et al., Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact, J Clin Pharm Ther, vol.38, issue.5, pp.360-72, 2013.

P. Gibert, M. Cabaret, M. Moulis, J. Bosson, J. Boivin et al., Optimizing medication use in elderly people in primary care: Impact of STOPP criteria on inappropriate prescriptions, Arch Gerontol Geriatr. avr, vol.75, pp.16-25, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02007335

S. De-germay, M. Rueter, F. Montastruc, V. Rousseau, M. Lapeyre-mestre et al., Trends of atropinic (anticholinergic) exposure in the elderly: a 10-year analysis in the French EGB database, Fundam Clin Pharmacol. août, vol.33, issue.4, pp.471-479, 2019.

M. S. Salahudeen, S. B. Duffull, and P. S. Nishtala, Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review, BMC Geriatr. 25 mars, vol.15, p.31, 2015.

L. Andre, A. Gallini, F. Montastruc, J. Montastruc, A. Piau et al., Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review, Eur J Clin Pharmacol. déc, vol.75, issue.12, pp.1631-1675, 2019.

M. Laroche, F. Bouthier, M. L. Charmes, and J. , Médicaments potentiellement inappropriés aux personnes âgées : intérêt d'une liste adaptée à la pratique médicale française. La Revue de Médecine Interne, juill, vol.30, issue.7, pp.592-601, 2009.

J. Briet, H. Javelot, E. Heitzmann, L. Weiner, C. Lameira et al., The anticholinergic impregnation scale: Towards the elaboration of a scale adapted to prescriptions in French psychiatric settings, Therapie. sept, vol.72, issue.4, 2017.

H. Autorité-de-santé, , 2007.

N. Richard, État des lieux de la consommation des benzodiazépines en France

A. Clegg and J. B. Young, Which medications to avoid in people at risk of delirium: a systematic review, Age Ageing. janv, vol.40, issue.1, pp.23-32, 2011.

D. S. Kroll, H. R. Nieva, A. J. Barsky, and J. A. Linder, Benzodiazepines are Prescribed More Frequently to Patients Already at Risk for Benzodiazepine-Related Adverse Events in Primary Care, J Gen Intern Med, vol.31, issue.9, pp.1027-1061, 2016.

E. P. Peron, S. L. Gray, and J. T. Hanlon, Medication use and functional status decline in older adults: a narrative review, Am J Geriatr Pharmacother. déc, vol.9, issue.6, pp.378-91, 2011.

C. I. Neutel and H. L. Johansen, Association between hypnotics use and increased mortality: causation or confounding?, Eur J Clin Pharmacol. mai, vol.71, issue.5, pp.637-679, 2015.

R. C. Lucchetta, B. Da-mata, and C. Mastroianni-p-de, Association between Development of Dementia and Use of Benzodiazepines: A Systematic Review and Meta-Analysis, Pharmacotherapy, vol.38, issue.10, pp.1010-1030, 2018.

M. Ettcheto, J. Olloquequi, E. Sánchez-lópez, O. Busquets, A. Cano et al., Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia, Front Aging Neurosci, vol.11, p.344, 2019.

R. Penninkilampi and G. D. Eslick, A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias, CNS Drugs, vol.32, issue.6, pp.485-97, 2018.

D. M. Sobieraj, B. K. Martinez, A. V. Hernandez, C. I. Coleman, J. S. Ross et al., Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults, J Am Geriatr Soc, vol.67, issue.8, pp.1571-81, 2019.

S. J. Ralph and A. J. Espinet, Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care, J Alzheimers Dis Rep. 2 févr, vol.2, issue.1, pp.1-26, 2018.

C. Ballard and J. Waite, The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease, Cochrane Database Syst Rev. 25 janv, issue.1, p.3476, 2006.

T. Gallarda and H. Lôo,

, Encephale. juin, vol.35, issue.3, pp.269-80, 2009.

J. Norton, A. O. Engberink, C. Gandubert, K. Ritchie, A. Mann et al., Health Service Utilisation, Detection Rates by Family Practitioners, and Management of Patients with Common Mental Disorders in French Family Practice, Can J Psychiatry, vol.62, issue.8, pp.521-551, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01792140

A. J. Mitchell, V. Bird, M. Rizzo, and N. Meader, Diagnostic validity and added value of the Geriatric Depression Scale for depression in primary care: a meta-analysis of GDS30 and GDS15, J Affect Disord. sept, vol.125, issue.1-3, pp.10-17, 2010.

Y. Krishnamoorthy, S. Rajaa, and T. Rehman, Collège national des universitaires en psychiatrie, Association pour l'enseignement de la sémiologie psychiatrique. Item 108: Troubles du sommeil de l'enfant et de l'adulte, Référentiel de Psychiatrie, vol.87, 2020.

, Collège national des universitaires en psychiatrie, Disponible sur, p.592, 2014.

6. Item, Edition n°2. Presses Universitaires Francois Rabelais, Trouble dépressif de l'adolescent et de l'adulte, p.592, 2014.

, Edition n°2. Presses Universitaires Francois Rabelais, Item 64B: Trouble anxieux généralisé, p.592, 2014.

, Les Parcours de Soins, 2018.

D. Sur,

J. R. Mort and R. R. Aparasu, Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly, Arch Intern Med, vol.160, issue.18, pp.2825-2856, 2000.

I. Fulone and L. C. Lopes, Potentially inappropriate prescriptions for elderly people taking antidepressant: comparative tools, BMC Geriatr, vol.02, issue.1, p.278, 2017.

H. Cho, J. Choi, Y. Kim, S. J. Son, K. S. Lee et al., Prevalence and predictors of potentially inappropriate prescribing of central nervous system and psychotropic drugs among elderly patients: A national population study in Korea, Arch Gerontol Geriatr. janv, vol.74, pp.1-8, 2018.

E. Tommelein, E. Mehuys, M. Petrovic, A. Somers, P. Colin et al., Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review, Eur J Clin Pharmacol. déc, vol.71, issue.12, pp.1415-1442, 2015.

J. Heeringa, D. Van-der-kuip, A. Hofman, J. A. Kors, G. Van-herpen et al., Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, Eur Heart J. avr, vol.27, issue.8, pp.949-53, 2006.

A. Singh-manoux, A. Fayosse, S. Sabia, M. Canonico, M. Bobak et al., Atrial fibrillation as a risk factor for cognitive decline and dementia, Eur Heart J. 7 sept, vol.38, issue.34, pp.2612-2620, 2017.

A. Santos, D. T. Da-silva, S. Júnior, G. A. Silvestre, C. C. Nunes et al., Evaluation of the heterogeneity of studies estimating the association between risk factors and the use of potentially inappropriate drug therapy for the elderly: a systematic review with meta-analysis, Eur J Clin Pharmacol. sept, vol.71, issue.9, pp.1037-50, 2015.

E. Olariu, C. G. Forero, J. I. Castro-rodriguez, R. -. Calvo, M. T. Álvarez et al., Detection of anxiety disorders in Primary care: a meta-analysis of assisted and unassisted diagnoses, Depress Anxiety. juill, vol.32, issue.7, pp.471-84, 2015.

Y. Gaboreau, P. Imbert, J. Jacquet, F. Paumier, P. Couturier et al., Factors affecting dementia screening by general practitioners in community-dwelling elderly populations: a large cross-sectional study in 2 areas of France, Alzheimer Dis Assoc Disord. mars, vol.28, issue.1, pp.58-64, 2014.

L. Lang, A. Clifford, L. Wei, D. Zhang, D. Leung et al., Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis, BMJ Open, vol.03, issue.2, 2017.

, Presse Med. janv, vol.47, issue.1, pp.75-83, 2018.

C. Helmer, K. Pérès, L. Letenneur, L. M. Guttiérez-robledo, H. Ramaroson et al., Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity, Dement Geriatr Cogn Disord, vol.22, issue.1, pp.87-94, 2006.

Y. Gaboreau, P. Imbert, J. Jacquet, R. Vericourt, G. Couturier et al., Barriers to and promoters of screening for falls in elderly community-dwelling patients by general practitioners: a large cross-sectional survey in two areas of France, Arch Gerontol Geriatr. août, vol.65, pp.85-91, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02008466

, Association pour l'enseignement de la sémiologie psychiatrique. Item 68: Troubles psychiques du sujet âgé, Référentiel de Psychiatrie, 2014.

J. Fagot, A. Cuerq, S. Samson, and A. Fagot-campagna, Cohort of one million patients initiating antidepressant treatment in France: 12-month follow-up, Int J Clin Pract. sept, vol.70, issue.9, pp.744-51, 2016.

G. Thornicroft, S. Chatterji, S. Evans-lacko, M. Gruber, N. Sampson et al., Undertreatment of people with major depressive disorder in 21 countries, Br J Psychiatry, vol.210, issue.2, pp.119-143, 2017.

Y. Lecrubier, Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies, J Clin Psychiatry, vol.68, issue.2, pp.36-41, 2007.

L. Pont, F. Letrilliart, L. Massari, V. Dorléans, Y. Thomas et al., Suicide and attempted suicide in France: results of a general practice sentinel network, Br J Gen Pract. avr, vol.54, issue.501, pp.282-286, 1999.

S. Richard-devantoy and F. Jollant, Le suicide de la personne âgée : existe-t-il des spécificités liées à l'âge ? smq, vol.37, pp.151-73, 2012.

A. T. Page, R. M. Clifford, K. Potter, D. Schwartz, and C. D. Etherton-beer, The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis, Br J Clin Pharmacol, vol.82, issue.3, pp.583-623, 2016.

H. E. Bloomfield, N. Greer, A. M. Linsky, J. Bolduc, T. Naidl et al., Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis, J Gen Intern Med, vol.20, issue.2020

A. Lasserre, N. Younès, T. Blanchon, I. Cantegreil-kallen, C. Passerieux et al., Psychotropic drug use among older people in general practice: discrepancies between opinion and practice, Br J Gen Pract. avr, vol.60, issue.573, pp.156-162, 2010.

E. Reeve, M. Ong, A. Wu, J. Jansen, M. Petrovic et al., A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people, Eur J Clin Pharmacol. août, vol.73, issue.8, pp.927-962, 2017.

G. Irving, A. L. Neves, H. Dambha-miller, A. Oishi, H. Tagashira et al., International variations in primary care physician consultation time: a systematic review of 67 countries, BMJ Open, vol.7, issue.10, p.17902, 2017.

P. Fayolle, Évaluation par les médecins généralistes de l'outil STOPP-START dans la détection des prescriptions médicamenteuses potentiellement inappropriées chez la personne âgée, 2012.

A. Frey-geoffret and . Critères, START version 2: étude de faisabilité de l'utilisation d'une version informatisée en médecine générale, 2016.

R. Sauvan, Impact de l'utilisation par les médecins généralistes de STOPP/START V2 pour optimiser les traitements de leurs patients de plus de 65 ans